Search research articles
Contact Us
Filters
Showing results (111-120 of 307) with videos related to
Page
of 31
Sort By:
Movement Disorders : Official Journal of the Movement Disorder Society
|
September 25, 2004
Parkinsonism, FXTAS, and FMR1 premutations
Mathias Toft, Jan Aasly, Gina Bisceglio, et al.
Parkinsonism & Related Disorders
|
March 15, 2001
Positron emission tomography in pallido-ponto-nigral degeneration (PPND) family (frontotemporal dementia with parkinsonism linked to chromosome 17 and point mutation in tau gene)
P K. Pal, Z K. Wszolek, A Kishore, et al.
Neurology
|
March 1, 1995
Western Nebraska family (family D) with autosomal dominant parkinsonism
Z K Wszolek, B Pfeiffer, J R Fulgham, et al.
Parkinsonism & Related Disorders
|
October 20, 2006
Aprataxin (APTX) gene mutations resembling multiple system atrophy
Yasuhiko Baba, Ryan J Uitti, Kevin B Boylan, et al.
Parkinsonism & Related Disorders
|
September 24, 2009
Histamine N-methyltransferase Thr105Ile is not associated with Parkinson's disease or essential tremor
Brett H Keeling, Carles Vilariño-Güell, Alexandra I Soto-Ortolaza, et al.
Mayo Clinic Proceedings
|
January 13, 2001
Simultaneous thalamic deep brain stimulation and implantable cardioverter-defibrillator
A A Obwegeser, R J Uitti, M F Turk, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
December 10, 1999
The effect of dopamine agonist therapy on dopamine transporter imaging in Parkinson's disease
J E Ahlskog, R J Uitti, M K O'Connor, et al.
Parkinsonism & Related Disorders
|
July 4, 2016
Cancer in Parkinson's disease
Pawel Tacik, Sadie Curry, Shinsuke Fujioka, et al.
Neurology
|
June 1, 1996
Amantadine treatment is an independent predictor of improved survival in Parkinson's disease
R J Uitti, A H Rajput, J E Ahlskog, et al.
Mayo Clinic Proceedings
|
June 1, 1997
Tropicamide eyedrops cannot be used for reliable diagnosis of Alzheimer's disease
N R Graff-Radford, S C Lin, P W Brazis, et al.
Page
of 31
Search research articles
Search
Showing results (111-120 of 307) with videos related to
Sort By:
Page
of 31
Movement Disorders : Official Journal of the Movement Disorder Society
|
September 25, 2004
Parkinsonism, FXTAS, and FMR1 premutations
Mathias Toft, Jan Aasly, Gina Bisceglio, et al.
Parkinsonism & Related Disorders
|
March 15, 2001
Positron emission tomography in pallido-ponto-nigral degeneration (PPND) family (frontotemporal dementia with parkinsonism linked to chromosome 17 and point mutation in tau gene)
P K. Pal, Z K. Wszolek, A Kishore, et al.
Neurology
|
March 1, 1995
Western Nebraska family (family D) with autosomal dominant parkinsonism
Z K Wszolek, B Pfeiffer, J R Fulgham, et al.
Parkinsonism & Related Disorders
|
October 20, 2006
Aprataxin (APTX) gene mutations resembling multiple system atrophy
Yasuhiko Baba, Ryan J Uitti, Kevin B Boylan, et al.
Parkinsonism & Related Disorders
|
September 24, 2009
Histamine N-methyltransferase Thr105Ile is not associated with Parkinson's disease or essential tremor
Brett H Keeling, Carles Vilariño-Güell, Alexandra I Soto-Ortolaza, et al.
Mayo Clinic Proceedings
|
January 13, 2001
Simultaneous thalamic deep brain stimulation and implantable cardioverter-defibrillator
A A Obwegeser, R J Uitti, M F Turk, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
December 10, 1999
The effect of dopamine agonist therapy on dopamine transporter imaging in Parkinson's disease
J E Ahlskog, R J Uitti, M K O'Connor, et al.
Parkinsonism & Related Disorders
|
July 4, 2016
Cancer in Parkinson's disease
Pawel Tacik, Sadie Curry, Shinsuke Fujioka, et al.
Neurology
|
June 1, 1996
Amantadine treatment is an independent predictor of improved survival in Parkinson's disease
R J Uitti, A H Rajput, J E Ahlskog, et al.
Mayo Clinic Proceedings
|
June 1, 1997
Tropicamide eyedrops cannot be used for reliable diagnosis of Alzheimer's disease
N R Graff-Radford, S C Lin, P W Brazis, et al.
Page
of 31